forbion.png
Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million
June 09, 2022 02:00 ET | Forbion
Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million New fund to invest in late-stage European life sciences companiesInvestors include Pantheon, pension funds PME...
ARMGO logo.jpg
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases
December 20, 2021 07:00 ET | ARMGO
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and joined by Pontifax and Kurma...